Synergistic effect of clinically available β lactamases inhibitors on cefiderocol activity against carbapenemase producing Gram negative organisms
Not available.
Main Authors: | G. Bianco, S. Comini, P. Gaibani, M. Boattini, G. Banche, C. Costa, P. Nordmann, R. Cavallo |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2023-04-01
|
Series: | Microbiologia Medica |
Online Access: | https://pagepressjournals.org/index.php/mm/article/view/11367 |
Similar Items
-
Synergistic Effect of Clinically Available Beta-Lactamase Inhibitors Combined with Cefiderocol against Carbapenemase-Producing Gram-Negative Organisms
by: Gabriele Bianco, et al.
Published: (2022-11-01) -
Disc Diffusion and ComASP<sup>®</sup> Cefiderocol Microdilution Panel to Overcome the Challenge of Cefiderocol Susceptibility Testing in Clinical Laboratory Routine
by: Gabriele Bianco, et al.
Published: (2023-03-01) -
Synergistic Activity of Cefiderocol in Combination with Piperacillin-Tazobactam, Fosfomycin, Ampicillin-Sulbactam, Imipenem-Relebactam and Ceftazidime-Avibactam against Carbapenem-Resistant Gram-Negative Bacteria
by: Marta Palombo, et al.
Published: (2023-05-01) -
In Vitro Activity of Cefiderocol Compared to Other Antimicrobials against a Collection of Metallo-Beta-Lactamase-Producing Gram-Negative Bacilli from Southern Spain
by: M. Delgado-Valverde, et al.
Published: (2023-06-01) -
The solution to drug resistance of Gram-negative bacteria – Cefiderocol
by: Magdalena Kołodziej, et al.
Published: (2023-05-01)